Similar observation was also found in HT29 Oxa-R cells in response to oxaliplatin (Fig. 5b), suggesting that REV7 is a potential target for 5-FU and oxaliplatin resistant CRC patients. The gene discussed is MAD2L2; the disease is colorectal carcinoma.